India's Serum Institute to boost vaccine exports gradually, report says

The Serum Institute of India, which produces the AstraZeneca COVID-19 vaccine, will resume small exports via the global vaccine-sharing platform COVAX this month and raise it substantially by January, its head told The Telegraph.

migrator

Updated:1st Oct, 2021 at 1:57 PM

New Delhi

"Our exports to COVAX will recommence again in October, initially these supplies will be small but by January 2022, once we have satisfied domestic demands – people forget that India is still a lower-middle-income country – we will see large volumes go to COVAX," Chief Executive Adar Poonawalla said.

Visit news.dtnext.in to explore our interactive epaper!

Download the DT Next app for more exciting features!

Click here for iOS

Click here for Android

India's Serum Institute to boost vaccine exports gradually, report says

The Serum Institute of India, which produces the AstraZeneca COVID-19 vaccine, will resume small exports via the global vaccine-sharing platform COVAX this month and raise it substantially by January, its head told The Telegraph.

Also Read

Tiruvallur gas leak deaths: December inspection had flagged fault in ammonia pipes. Six months on, zero action, 9 deaths

All eyes on GCC council meet

From bondage to books: Education breaks chain of bonded labour

Residents seek answers as Pattabiram ROB remains mired in disputes

Assistant professor recruitment candidates flag discrepancies in work experience marks